GVHD
GVHD
Advertisement
Katie KoskoGVHD | July 26, 2024
In the United States, 33%-50% of patients receiving an allogeneic transplant develop acute GVHD.
Read More
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | July 9, 2024
There are 5 types of immune-mediated cytopenias, each with provisional diagnostic criteria.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | July 9, 2024
Nurses have a critical role in managing cGVHD-related serositis, including patient assessment, direct care, and education.
Katie KoskoConferences | July 5, 2024
Researchers presented real-world data on the cGVHD treatment during the EHA 2024 Congress.
Katie KoskoGVHD | July 4, 2024
Certain predictive markers may help identify patients who "experience significant benefits" from upfront use of this therapy.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | June 27, 2024
Since TAC levels must remain in a therapeutic range, oncology nurses often draw blood levels before the morning dose.
Mairéad Ní Chonghaile, RGN, BNS, MScConferences | June 27, 2024
Mairéad Ní Chonghaile, RGN, BNS, MSc, speaks about the importance of staying current on the latest updates in the field.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | June 26, 2024
Although the term “atypical cGVHD” is imperfect, it describes a form of cGVHD that doesn’t fit neatly into classic ...
Katie KoskoGVHD | June 17, 2024
Nearly all patients in the study had steroid-dependent chronic GVHD, and nearly half had severe chronic GHVD.
Cecilia BrownGVHD | June 6, 2024
A new study shows why it's important for nurses to help optimize health care resource availability for certain patients.
Cecilia BrownGVHD | June 4, 2024
More than half of the patients receiving belumosudil were able to have a corticosteroid dose reduction.
Cecilia BrownGVHD | June 3, 2024
Research suggests that patients are asked to make transplant decisions based on variable information.
Cecilia BrownConferences | April 26, 2024
Jamie Oliva, PhD, ANP-BC, FNAP, BMTCN, discusses results she presented at the 49th Annual ONS Congress.
Cecilia BrownGVHD | April 19, 2024
A study of children with chronic GVHD showed that none reported having positive experiences at school.
Cecilia BrownGVHD | April 1, 2024
Researchers evaluated oral suspensions because patients with certain types of GVHD may have difficulty swallowing a tablet.
Cecilia BrownGVHD | April 1, 2024
Researchers surveyed nurses at centers with a high volume of allogeneic HSCT.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | March 1, 2024
The GI tract, commonly called “the gut,” is a frequent target of GVHD, in particular aGVHD.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | March 7, 2024
Dealing with the long-term, life-altering, uncomfortable symptoms of chronic GVHD can be difficult to accept.
Mary Mansour Riwes, DOConferences | March 1, 2024
Mary Mansour Riwes, DO, explains what she saw as the important news in GVHD at the 2024 Tandem Meetings.
Mary Mansour Riwes, DOConferences | February 26, 2024
Mary Mansour Riwes, DO, speaks about research on the topic that she presented at the 2024 Tandem Meetings.
Advertisement
Advertisement
Advertisement